9999999997-15-009962.txt : 20150520 9999999997-15-009962.hdr.sgml : 20150520 20150520112215 ACCESSION NUMBER: 9999999997-15-009962 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150520 DATE AS OF CHANGE: 20150520 20150520 20150520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARCA biopharma, Inc. CENTRAL INDEX KEY: 0000907654 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 363855489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-22873 FILM NUMBER: 15878623 BUSINESS ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 BUSINESS PHONE: 720-940-2200 MAIL ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 FORMER COMPANY: FORMER CONFORMED NAME: NUVELO INC DATE OF NAME CHANGE: 20030203 FORMER COMPANY: FORMER CONFORMED NAME: HYSEQ INC DATE OF NAME CHANGE: 19970610 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-"B6UM;6U#0HQ(#`@;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#$O2VED'0O26UA9V5"+TEM86=E0R]);6%G94E=(#X^+TUE9&EA0F]X6R`P(#`@-C$R M(#2]#4R]$979I8V521T(^/B]486)S+U,O4W1R=6-T4&%R96YT M)R-66UOVS@,_EZ@_T'`?;&!1K,D MRR^'84"6MEN&:WN79L"`[7!(&K/^/^2Z:?+BQM0)C=W(T*.D-D1<@LG@H@&DD2II"Q4 M<*^`\!Z0A%'A!")Z0**82B>0L`.$RX2RF$12T+@%^7SOA]YXZ@^$=^,/N'=- M'N$E](;3&_SL\6@-PQ[`2*4)U6N/[+"'Q1&-$Q*)E*8MR./>DM%GL&PRGH[Q M17VBOB-#M/B:W'SQ&?-&']7K!S_1(F3T<.'7CVB(TII_'!O<204$-O4 MM*'7D:AK8V-&$]@-'AWR!"V8_2:697D*H1"F!@]LF\V",^$KP@,F;0HA*)S8 MT^M4W)-RC#OF;=(5XHC1D!,)[N[S]F%R?3,A'_S4FPPQ5O?3\3T&D/B#U!L] MW-_Z#")V?7,_Q8B.AW\1E9$3"#`+(#'O_"9#0,`25!E0*TU/NTR':DF) M3,*38D'CIQ_W:4I>SUCUZY<1?`G9^L$')[3F$#]23I*'6]@.PE(16ET2-(A- M<_KY+.CPJ>%'&0>.V M?(6>9>CO?4FM90X,%S)3W5;E/.%4"E-V8)4%W-24Y3R)A95!SN5M-@N6GLG: M[!!!)3'INQNE8&C\Y[Y)&6FAJT:0QABDA-T3K;^(%+>?M_A MLT+'P.D7[$,VGV0``\U)X/56613:K(I#K#RM@*O]PJ2HLZ+*82?+9]CIR".; M;>;'WH^\W%6J^;UL9_!>U"A@S01).3/Q,5)E\9PO_$&B%BMTS-#0%5%!5@NI M:,+LP+QU!HL\P_A0;N%!\N*Y5*UI5J-Y.CE(AIRD[,8%5KM%M@`=Z6W+]6O> M1P&-6^OJ90:-7VBD93[7Z!4!@^J2S,@M3#S*C#6T:IO7.'L)$]?:$H#B>6K* M_J,,/[2J!2FM$>21KLMC_>$.]T)ERJZJT4X(%TR>Z%)@M5J$,3*>@63M]3BI MG:S:SVE=HVJ[_S"7I&XH7;-JBP(MOY-?NYCQ6/9]DVM5!E'56PW[I%)PLR]" M]651JXR#[&=3&#WA,97RG]8E_TC7U(ZEO`)UBF>@B),%20 MWZI0H-:1C&`_QZ`;&;JO>!3(`T4-T9KZBDCRF:JS`!WA$A2&6_[-`\CY-Q^> MW[P0?D9-/-"D:_3FA[)=4R>J/9.1LF-3*L+<=RBT7;O>CJ1+O96+K,Z0[+?K MO-!)692U9L;R%3=$R@X5N=G-#\UQI397Y^LBKYY69961O*:$@+KU,E4,RR0N[9:F;+9X9)' MNW?4?C#.=;[>!VVCQHR\7)`*E=0KJF`=+?ZT3IEZ$XYM[*>^KK-NZVD4.HZ6 MO.=TB9P.7;LO="QZ3EE8UZ'TP61IJPXTBRWP%X<+[(NL%4PBS M0\SL]IV'O^M:H`V_B/`H7"-SZL&_JAK& MM(6)AS1(3;BKX_:LITA=V==`SVI\;29;H.:-FB:-P\,9-5\!)6RK';)&X4K% M>)O=VK/0K+.?R]1J0*+X`?Z^JY?E-J_59/';MFT)G"`3$]?&+RR1-(I,V?Z@ M=EVC-)YPO$AW0^DZD;)/NAM)UZ]RBX%6Z&TK/,9KC!;ACFKK):JYSD]5< MYR3+1>@NJ^G*2;:A*T,6!V$U]D*&?U*92'4A9*M%9;VSD31.[6N>1Z7G(,#Q M-M\U*DZR352<9)NHN,BV47&2;:+B(MM&Y5CVL:6@IY[+/*@K0TF%L9ZI/@*1 MC*R<@L>+4-BM.X]?SQ&,XQ\NW%!ZIIGF].SR%[>>:0;#Z<83HJ)SEEL]*Y$`0QN^"[U!OD-2?[B0@PK(JNX@BCK`' M\1#'WG%P)I&8`7W[K4Z-.(<];.JZ,*32G?I^J>I\]#0*E(`5!`2L`4L";``# M`Y7Z$R`$"@&(@,L(Q,"A`A*0LM8'(*$!BJK6;(5$`JHAHNH:B#&J""KE,D)5 ME<`$=28QU)4`"S2JY0!-I2E1WZ[I7&FL-4FK04UA+0?KJ"\$))T4+92:$D0K M9;T(:VRT(`$4T;R@L=$\Y86@>4[$8A]UR/-^D;7%Y#^4# M%#BP`#H\@`X3H,,%Z+`!.GQ`#A^09Q]P^(`ZZ6D^K>29::LWS,'3 MZ_0^7J8/P#WZ0EE=/Z;B.E_.NZ>OP9VF/O;OQ2(MQ^)':I_28/=9\WG_L]NL MN[1X;G.%>>);IX1V7/?=?CR,Z]^MWDRC7_WP\MCW+\59O]QMM:9IYNTYI=$< M<-4NA_Y@_/U9KP?CLW6[Z5<'$XO-^BD=Y-I[-&TUM-OB8KW:#6G?Z_5N^W:? MC[KA:W7_=THP%:@P+H`D$+-$$-]+(8_^"#/UGR.]@B6D7AM`>1 M+V=X&NYAQ%')E9@T*-3$U-`T*)25%3T8-"GAR968-"C`@,`T*=')A:6QE<@T*/#PO4VEZ M92`U-2]2;V]T(#$@,"!2+TEN9F\@.2`P(%(O241;/#(V03,X04,X1C')E ..9@T*-C0P.0T*)25%3T8_ ` end